Myasthenia gravis represents chronic autoimmune condition that primarily targets the neuromuscular junction. This junction mediates the transfer of signals from nerves to muscles, enabling movement. In myasthenia gravis, the body's immune system mistakenly attacks these receptors, leading weakness and fatigue in the skeletal tissues. The manifesta